Our People

Dave Cook, PhD Strategic Advisor

David Cook is the Chief Scientific Officer and Executive Vice President of R&D and of Seres Therapeutics, an emerging biopharma developing drugs from the microbiome. He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career.

Before joining Seres he was the Chief Operating Officer for the International AIDS Vaccine Initiative, whose mission is to develop a safe, globally accessible vaccine for HIV. Prior to IAVI, David was the founding CEO at Anza Therapeutics, a start-up that developed a novel immunotherapy platform that is now in advanced trials in patients with pancreatic cancer and mesothelioma.

Before launching Anza, Dr. Cook held positions of increasing responsibility at the biotechnology corporations Cerus and Eligix, overseeing R&D, program management, manufacturing, and clinical and regulatory affairs. He has led teams that developed and commercialized multiple approved products in the U.S. and Europe. He is also an inventor on more than 50 patents and applications.

Dr. Cook earned his undergraduate degree from Harvard College and his Ph.D. in chemistry from the University of California, Berkeley.

Back to All